Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance

Journal of Urology

Volumn 160, Issue 3 I, 1998, Pages 768-771

  Hao, D ^a   Seidel, J ^a   Brant, R ^a   Alexander, F ^a   Ernst, D S ^a   Summers, N ^a   Russell, J A ^a   Stewart, D A ^a  

^a NONE

Author keywords

Compliance; Immunologic surveillance; Testicular neoplasms

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONTROLLED STUDY; HUMAN; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032324190     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62782-4     Document Type: Article

References (20)

1. Nichols, C. R., Timmerman, R., Foster, R. S., Roth, B. J. and Einhorn, L. H.: Neoplasms of the Testis. In: Cancer Medicine, 4th ed. Edited by J. F. Holland, R. C. Bast, Jr., D. L. Morton, E. Frei, III, D. W. Kufe and R. R. Weichselbaum. Baltimore: Williams & Wilkins, vol. 2, chapt. 140, pp. 2177-2211, 1997.
2. Hoskins, P., Dilly, S., Easton, D., Horwich, A., Hendry, W. and Peckham, M. J.: Prognostic factors in stage I nonseminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J. Clin. Oncol., 4: 1031, 1986.
3. Rorth, M., Jacobsen, G. K., von der Masse, H., Madsen, E. L., Nielsen, O. S., Pedersen, M., Schultz, H. and the Danish Testicular Cancer Study Group: Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. J. Clin. Oncol., 9: 1543, 1991.
4. Gels, M. E., Hoekstra, H. J., Sleijfer, D. T., Marrink, J., de Bruijn, H. W., Molenaar, W. M., Freling, N. J., Droste, J. H. and Schraffordt Koops, H. S.: Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single center 10-year experience. J. Clin. Oncol., 13: 1188, 1995.
5. Read, G., Stenning, S. P., Cullen, M. H., Parkinson, M. C., Horwich, A., Kaye, S. B. and Cook, P. A. for the Medical Research Council Testicular Tumors Working Party: Medical Research Council prospective study of surveillance for stage I testicular teratoma. J. Clin. Oncol., 10: 1762, 1992.
6. Nicolai, N. and Pizzocaro, G.: A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J. Urol., 154: 1045, 1995.
7. Javadpour, N.: Prognostic factors in nonseminomatous testicular cancer. Testicular Cancer, Prog. Clin. Biol. Res., 203: 271, 1985.
8. Fung, C. Y., Kalish, L. A., Brodsky, G. L., Richie, J. P. and Garnick, M. B.: Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology. J. Clin. Oncol., 6: 1467, 1988.
9. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Amer. Stat. Assn., 53: 457, 1958.
10. Andersen, P. K. and Gill, R. D.: Cox's regression model for counting processes: a large sample study. Ann. Stat., 10: 1100, 1982.
11. International Germ Cell Cancer Collaborative Group: International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J. Clin. Oncol., 15: 594, 1997.
12. Klepp, O., Olsson, A. M., Henrikson, H., Aass, N., Dahl, O., Stenwig, A. E., Persson, B., Cavallin-Stahl, E., Fossa, S. D. and Wahlqvist, L. for the Swedish-Norwegian Testicular Cancer Group: Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. J. Clin. Oncol., 8: 509, 1990.
13. Given, B. A. and Given, C. W.: Compliance among patients with cancer. Oncol. Nurs. Forum, 16: 97, 1989.
14. Young, B. J., Bultz, B. D., Russell, J. A. and Trew, M. S.: Compliance with follow-up of patients treated for nonseminomatous testicular cancer. Brit. J. Cancer., 64: 606, 1991.
15. Pont, B. J., Höltl, W., Kosak, D., Machacek, E., Kienzer, H., Julcher, H. and Honetz, N.: Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial. J. Clin. Oncol., 8: 16, 1990.
16. Hoeltl, W., Pont, J., Kosak, D., Honetz, N. and Marberger, M.: Treatment decision for stage I nonseminomatous germ cell tumors based on risk factor "vascular invasion." Brit. J. Urol., 62: 83, 1992.
17. Baniel, J., Roth, B. J., Foster, S. and Donohue, J. P.: Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors. Ann. Surg. Oncol., 3: 86, 1996.
18. Baniel, J., Foster, R. S., Rowland, R. G., Bihrle, R. and Donohue, J. P.: Complications of primary retroperitoneal lymph-node dissection for low stage testicular cancer. World J. Urol., 12: 139, 1994
19. Cullen, M. H., Stenning, S. P., Parkinson, M. C., Fossa, S. D., Kaye, S. B., Horwich, A. H., Harland, S. J., Williams, M. V. and Jakes, R. for the Medical Research Council Testicular Tumor Working Party: Short course adjuvant chemotherapy in high risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J. Clin. Oncol., 14: 1106, 1996.
20. Stephenson, W. T., Poirier, S. M., Rubin, L. and Einhorn, L. H.: Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide and bleomycin. J. Clin. Oncol., 13: 2278, 1995.